1. EMA.Benefit‐Risk methodology. European Medicines Agency.http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/document_listing/document_listing_000314.jsp&mid=WC0b01ac0580981014. Published 2019. Accessed May2019.
2. Benefit-Risk Assessments at the US Food and Drug Administration
3. FDA.Benefit‐Risk Assessment in Drug Regulatory Decision‐Making Draft PDUFA VI Implementation Plan (FY 2018–2022).2018.
4. JenkinsJ.A United States regulator's perspective on risk‐benefit considerations. Risk‐benefit considerations in drug regulatory decision‐making. Paper presented at Shady Grove Conference Center 2010; Rockville MD
5. FDA.Statement from FDA Commissioner Scott Gottlieb M.D. on FDA's efforts to enhance the patient perspective and experience in drug development and review.2018.